Cardiac Amyloidosis
Our Approach to Cardiac Amyloidosis
The Montefiore Einstein Cardiac Amyloidosis Program offers state-of-the-art diagnostic and therapeutic services and highly personalized treatment plans to help mitigate symptoms in patients with cardiac amyloidosis. Our multidisciplinary team of experts collaborates closely across departments to provide access to the latest clinical trials and innovative therapies. We’re ranked in the top 1% of all hospitals in the nation for Cardiology, Heart & Vascular Surgery according to U.S. News & World Report.
Advanced Treatments
We provide a comprehensive range of treatment options for all forms of cardiac amyloidosis. Treatments include:
- Chemotherapy
- Stem cell transplant
- Immunotherapy
- Liver transplant
- Genetic stabilizers
- Fibril inhibitors
- Heart transplant
- Antiarrhythmic medication
- Implantable devices
- Diuretic medications
Diagnostic Testing for Cardiac Amyloidosis
Cardiac amyloidosis is a condition where faulty proteins build up in your heart. This condition can be inherited or it can develop on its own, typically later in life. We offer a wide spectrum of advanced diagnostic testing for patients with cardiac amyloidosis symptoms.
- Blood testing
- Echocardiogram (heart ultrasound)
- Nuclear medicine technetium pyrophosphate scanning
- Magnetic Resonance Imaging (MRI)
- Electrocardiogram (ECG)
- Tissue biopsy
- Bone marrow biopsy
- Nerve conduction study
- Genetic testing
Your Heart Team
Our multidisciplinary team includes specialists in cardiovascular medicine, cardiac pathology, cardiac imaging, cardiac surgery, and cardiac research, who collaborate across departments to provide an extensive range of treatment options and improve clinical outcomes and overall quality of life.
Mario J. Garcia, MD
Aldo L. Schenone, MD
Yogita M. Rochlani, MD
